Skip to main content
SpringerLink
Log in

Does BMI affect the detection of sentinel lymph nodes with indocyanine green in early breast cancer patients?

  • original article
  • Published:
European Surgery Aims and scope Submit manuscript

Summary

Background

Sentinel node biopsy (SNB) has proved to be a useful and safe method for axillary staging in the surgical management of early breast cancer. Sentinel node (SN) detection rates with blue dye (patent blue) and radioisotopes (99m-Tc), either alone or particularly in combination, are high (95% to 100%). Even better detection rates were reported with fluorescent dyes like indocyanine green (ICG). This study was designed to show whether sentinel node detection and mapping of lymphatics with ICG might depend on the body mass index (BMI).

Methods

Between February 2014 and April 2015, SNB with blue dye, 99m-Tc, and ICG navigation was conducted for 100 consecutive procedures in patients scheduled for surgery of early breast cancer. ICG injection, lymphatic mapping with the Photodynamic Eye (PDE; Hamamatsu Photonics, Hamamatsu, Japan), and identification of the sentinel nodes with blue dye and ICG were followed by a final search for more lymph nodes with a gamma probe. Data were collected prospectively.

Results

In all patients, up to six sentinel nodes (mean 2.49) were detected. No statistical correlation was found between the BMI and the identification of lymphatics or the detection of lymph nodes with ICG. Lymphatics were successfully identified preoperatively in no more than 79 cases. In 6 patients, a gamma probe was needed for detection. Adverse events or allergic reactions were absent throughout.

Conclusions

SN detection and lymphatic mapping with ICG were not related to the BMI. Pending answers to as yet unsolved questions, the combined use of blue dye and 99m-Tc imaging should, however, be continued.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997;15(6):2345–50.

    Article  CAS  PubMed  Google Scholar 

  2. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer – a multicenter validation study. N Engl J Med. 1998;339(14):941–6.

    Article  CAS  PubMed  Google Scholar 

  3. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst. 1999;91(4):368–73.

    Article  CAS  PubMed  Google Scholar 

  4. Haid A, Koberle-Wuhrer R, Knauer M, Burtscher J, Fritzsche H, Peschina W, et al. Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat. 2002;73(1):31–6.

    Article  PubMed  Google Scholar 

  5. Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, Duffy SW. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol. 2005;23(19):4312–21.

    Article  PubMed  Google Scholar 

  6. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998;227(5):645–51, discussion 651–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Sugie T, Sawada T, Tagaya N, et al. Comparison of the Indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer. Ann Surg Oncol. 2012; doi:10.1245/s10434-013-2890-0.

    Google Scholar 

  8. Ballardini B, Santoro L, Sangalli C, Gentilini O, Renne G, Lissidini G, et al. The indocyanine green method is equivalent to the 99mtc-labeled radiotracer method for identifying the sentinel node in breast cancer: a concordance and validation study. Eur J Surg Oncol. 2013;39(12):1332–6.

    Article  CAS  PubMed  Google Scholar 

  9. Xiong L, Gazyakan E, Yang W, Engel H, Hünerbein M, Kneser U, Hirche C. Indocyanine green fluorescence-guided sentinel node biopsy: A meta-analysis on detection rate and diagnostic performance. Eur J Surg Oncol. 2014;40(7):843–9.

    Article  CAS  PubMed  Google Scholar 

  10. Kitai T, Inomoto T, Miwa M, Shikayama T. Fluorescence navigation with Indocyaningreen for detecting sentinel lymph nodes in breast cancer. Breast Cancer. 2005;12:211–5.

    Article  PubMed  Google Scholar 

  11. Grischke E‑M, Röhm C, Hahn M, Helms G, Bruckner S, Wallwiener D. ICG fluorescence technique for the detection of sentinel lymph nodes in breast cancer: results of a prospective open-label clinical trial. Geburtshilfe Frauenheilkd. 2015;75:935–40.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Samorani D, Fogacci T, Panzini I, Frisoni G, Accardi FG, Ricci M, et al. The use of indocyanine green to detect sentinel nodes in breast cancer: A prospective study. Eur J Surg Oncol. 2015;41(1):64–70.

    Article  CAS  PubMed  Google Scholar 

  13. Hojo T, Nagao T, Kikuyama M, Akashi S, Kinoshita T. Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer. Breast. 2010;19(3):210–3.

    Article  PubMed  Google Scholar 

  14. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349(6):546–53.

    Article  PubMed  Google Scholar 

  15. Chagpar AB, Martin RC, Scoggins CR, Carlson DJ, Laidley AL, El-Eid SE, et al. Factors predicting failure to identify a sentinel lymph node in breast cancer. Surgery. 2005;138(1):56–63.

    Article  PubMed  Google Scholar 

  16. Aoyama K, Kamio T, Ohchi T, Nishizawa M, Kameoka S. Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green. World J Surg Oncol. 2011;9:157.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Hirano A, Kamimura M, Ogura K, Kim N, Hattori A, Setoguchi Y, et al. A comparison of indocyanine green fluorescence imaging plus blue dye and blue dye alone for sentinel node navigation surgery in breast cancer patients. Ann Surg Oncol. 2012;19(13):4112–6.

    Article  PubMed  Google Scholar 

  18. Takeuchi M, Sugie T, Abdelazeem K, Kato H, Shinkura N, Takada M, et al. Lymphatic mapping with fluorescence navigation using indocyanine green and axillary surgery in patients with primary breast cancer. Breast J. 2012;18(6):535–41.

    Article  PubMed  Google Scholar 

  19. Tong M, Guo W, Gao W. Use of fluorescence imaging in combination with patent blue dye versus patent blue dye alone in sentinel lymph node biopsy in breast cancer. J Breast Cancer. 2014;17(3):250–5.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Wishart GC, Loh SW, Jones L, Benson JR. A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer. Eur J Surg Oncol. 2012;38(8):651–6.

    Article  CAS  PubMed  Google Scholar 

  21. Schaafsma BE, Verbeek FP, Rietbergen DD, van der Hiel B, van der Vorst JR, Liefers GJ, et al. Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer. Br J Surg. 2013;100(8):1037–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Murawa D, Hirche C, Dresel S, Hünerbein M. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence. Br J Surg. 2009;96(11):1289–94.

    Article  CAS  PubMed  Google Scholar 

  23. Ogasawara Y, Ikeda H, Takahashi M, Kawasaki K, Doihara H. Evaluation of breast lymphatic pathways with indocyanine green fluorescence imaging in patients with breast cancer. World J Surg. 2008;32(9):1924–9.

    Article  PubMed  Google Scholar 

  24. van der Vorst JR, Schaafsma BE, Verbeek FP, Hutteman M, Mieog JS, Lowik CW, et al. Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients. Ann Surg Oncol. 2012;19(13):4104–11.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Niebling MG, Pleijhuis RG, Bastiaannet E, Brouwers AH, van Dam GM, Hoekstra HJ. A systematic review and meta-analysies o sentinel lymph node identification in breastcancer and melanoma, a plea for tracer mapping. Eur J Surg Oncol. 2016; doi:10.1016/j.ejso.2015.12.007.

    PubMed  Google Scholar 

Download references

Funding

This study was supported by the Austrian Society of Senology.

Author information

Authors and Affiliations

  1. Breast Center Vorarlberg, Department of General, Visceral and Thoracic Surgery, Landeskrankenhaus Feldkirch, Carinagasse 47–49, 6800, Feldkirch, Austria

    Stephanie Rauch, Anton Haid & Etienne Wenzl

  2. Institute of Pathology, Landeskrankenhaus Feldkirch, Carinagasse 47–49, 6800, Feldkirch, Austria

    Zerina Jasarevic

  3. VIVIT Institute, Landeskrankenhaus Feldkirch, Carinagasse 47–49, 6800, Feldkirch, Austria

    Christoph H. Saely

  4. Department of Nuclear Medicine, Landeskrankenhaus Feldkirch, Carinagasse 47–, 6800, Feldkirch, Austria

    Alexander Becherer

Authors
  1. Stephanie Rauch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anton Haid
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zerina Jasarevic
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christoph H. Saely
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alexander Becherer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Etienne Wenzl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephanie Rauch.

Ethics declarations

Conflict of interest

S. Rauch, A. Haid, Z. Jasarevic, C.H. Saely, A. Becherer, and E. Wenzl declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rauch, S., Haid, A., Jasarevic, Z. et al. Does BMI affect the detection of sentinel lymph nodes with indocyanine green in early breast cancer patients?. Eur Surg 49, 165–170 (2017). https://doi.org/10.1007/s10353-017-0480-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10353-017-0480-2

Keywords

Search

Navigation